Futura Medical plc (LON:FUM – Get Free Report) fell 9.1% on Friday . The company traded as low as GBX 8.50 ($0.11) and last traded at GBX 9.20 ($0.12). 729,276 shares changed hands during mid-day trading, an increase of 8% from the average session volume of 672,447 shares. The stock had previously closed at GBX 10.13 ($0.13).
Futura Medical Price Performance
The firm has a market capitalization of £26.49 million, a PE ratio of -7.01 and a beta of 1.25. The company has a 50-day moving average price of GBX 14.20 and a 200-day moving average price of GBX 26.94.
Futura Medical Company Profile
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Featured Stories
- Five stocks we like better than Futura Medical
- Canada Bond Market Holiday: How to Invest and Trade
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- 5 Top Rated Dividend Stocks to Consider
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
- What Does a Stock Split Mean?
- 2 High-Yield Values for Dividend Growth and Capital Gains
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
